Neumora Therapeutics, Inc.
Clinical trials sponsored by Neumora Therapeutics, Inc., explained in plain language.
-
New depression pill shows promise in major clinical trial
Disease control CompletedThis completed Phase 3 study tested whether an investigational oral medication called NMRA-335140 could reduce symptoms of major depression compared to a placebo. The 6-week trial involved 383 adults with moderate to severe depression who were randomly assigned to receive either …
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug tested to calm agitation in Alzheimer's patients
Symptom relief CompletedThis early-stage study tested an experimental drug called NMRA-323511 to see if it is safe and can help reduce agitation in people with Alzheimer's disease. The trial involved 96 participants, including healthy elderly adults and people with Alzheimer's who experience agitation. …
Phase: PHASE1 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC